Phentolamine is framed as a differentiated, preservative-free sympatholytic approach that modulates pupil dynamics without ciliary muscle activation, targeting near-vision improvement while ...
The EnVision Summit—billed as the “ultimate gathering place for ophthalmic and optometric professionals”—has come to a close ...
The authors of a new study 1 emphasized the clear visual benefits that low-vision patients experience during low-vision ...
Real-world evidence links higher injection frequency to better VA outcomes and reduced CST fluctuations, reinforcing ...
Ocular Therapeutix has released positive topline results from SOL-1, its phase 3 superiority trial of AXPAXLI for the ...
In the United States, aflibercept-yszy received Food and Drug Administration (FDA) approval in May 2024 as a biosimilar to ...
The results of a phase 1b study that evaluated a potential new treatment for macular edema associated with inflammation, ...
Ophthalmology Times, hosted by Douglas D. Koch, MD, Professor and Allen, Mosbacher, and Law Chair in Ophthalmology at the ...
At Envision Summit 2026, the “Fast and Fundus” retina panel delivered rapid-fire case discussions grounded in practical ...
Phase 1b data show KSI-101 rapidly clears inflammatory macular edema, delivers long-lasting fluid control without steroids, ...
More recently established treatments for RVO have taken a giant leap forward from laser photocoagulation since intravitreally ...
As the use of glaucoma drainage implants (GDIs) continues to expand in clinical practice, surgeons are becoming more attuned ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results